DEC 05, 2019 5:00 AM PST

The clinical implications of high sensitive assays for HBsAg

Sponsored by: Abbott
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract
DATE:  December 5, 2019
TIME:   5:00am PST, 8:00am EST
 
The diagnosis of an active infection by the hepatitis B virus (HBV) relies on testing for the HBV surface antigen (HBsAg). Over the decades the sensitivity of HBsAg assays has increased, and the most recent solutions attain a level of 5 mIU/mL and enable to detect active HBV also at very low level of expression, with HBV-DNA levels <100 mIU/mL. The availability of such assays will help improve the safety of blood screening in settings that do not encompass testing for HBV-DNA and will enable unveiling HBsAg in a substantial share of "occult" or "latent" HBV infections (OBI). Unveiling OBIs has a great clinical relevance in immunocompromised or immunosuppressed patients and in people coinfected by other viruses, such as HCV or HIV. Additionally, since the negativity for HBsAg is a major endpoint for antiviral treatment with nucleosi(t)ide analogues, a higher sensitivity for HBsAg can help with a safer interruption of treatment.
 
Learning Objectives:
  • Review the natural history of HBV infection and the progress in HBsAg testing
  • Understand the mechanism and clinical implications of HBV reactivation
  • Acknowledge the medical improvements linked to a better sensitivity for HBsAg
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
JUN 08, 2021 9:00 AM PDT
JUN 08, 2021 9:00 AM PDT
Date: June 8, 2021 Time: 9:00am PDT Reducing the spread of highly infectious and deadly diseases within the population, vaccine development is crucial in saving millions of lives each year....
DEC 05, 2019 5:00 AM PST

The clinical implications of high sensitive assays for HBsAg

Sponsored by: Abbott
C.E. Credits: P.A.C.E. CE Florida CE


Show Resources
Loading Comments...
Show Resources